Project Details
Description
CD133-Targeted Natural Killer Cell Therapy for Aggressive Variant Prostate Cancer
Status | Finished |
---|---|
Effective start/end date | 12/31/18 → 4/30/21 |
Funding
- PROSTATE CANCER FOUNDATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.